Enrique Poradosu

Chief Science & Business Off at Nuvectis Pharma · 1 reported transaction in 1 company · latest report Jan 6, 2026

Their trades


Nuvectis PharmaNVCT	Share award — · 150,000 shares	Jan 6, 2026

Jan 6, 2026 · NVCT

150,000

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Science & Business Off at Nuvectis Pharma · 1 reported transaction in 1 company · latest report Jan 6, 2026


Nuvectis PharmaNVCT	Share award — · 150,000 shares	Jan 6, 2026

Jan 6, 2026 · NVCT

150,000

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.